Illumina, Inc. and Solexa, Inc. have announced that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger ...
Illumina dominates genomics sequencing with recurring growth, NovaSeq X catalysts, and improving margins/FCF. Click to know ...
We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...
Why has Illumina stock lost one third of its value in the 12 months from August 1, 2023 to August 1, 2024? Why are some scientists, such as those I have heard at genomics conferences, discussing the ...
NEW YORK (Reuters) - Gene-testing technology company Illumina Inc. will acquire Solexa Inc. in a stock deal valuing the developer of genetic analysis systems at about $600 million, the companies said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results